Henry Rusinek

New York University

Papers

1

Total Citations

21

H-Index

1

About

Dr. Henry Rusinek is a leading researcher in medical imaging, with a focus on advancing the diagnosis and characterization of prostate cancer through innovative multi-modal imaging techniques. His major contribution lies in developing a platform for the precise 3D co-registration of in-vivo MRI, ex-vivo MRI, and pathology, a critical step in correlating pre-surgical imaging findings with actual tissue pathology. This work, detailed in his highly cited 2012 paper (21 citations), directly addresses the significant challenge of accurately localizing cancerous lesions detected by multi-parametric MRI. By enabling a direct comparison between in-vivo images and the gold standard of histology, Dr. Rusinek’s platform provides a robust framework for validating and improving MRI-based cancer detection, prognosis, and treatment planning. His research has a tangible impact on clinical practice, helping to refine the accuracy of non-invasive cancer diagnosis and reduce the need for unnecessary biopsies. Dr. Rusinek’s work exemplifies the power of cross-disciplinary imaging science to solve critical problems in oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
21
Total Citations
21
Avg Citations/Paper
🏆 Most Cited Paper
Imaging of prostate cancer: a platform for 3D co-registration of in-vivo MRI ex-vivo MRI and pathology
21 citations · 2012
📈 Most Prolific Year: 2012 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: New York University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago